The Evolving Role of Nuclear Medicine and Molecular Imaging: Theranostics and Personalized Therapeutic Applications

EditorialMol Imaging Radionucl Ther 2018;27:1-2 DOI:10.4274/mirt.305021During the last decade, there have been excellent and very rapid advances in “Nuclear Medicine and Molecular Imaging” throughout the world. The developments in radiopharmaceuticals induced evolution of nuclear medicine from imaging certain biologic features to targeted drug delivery designed for the specific characteristics of an individual patient’s disease. While the use of therapeutic radioisotopes was an important but minor component of the therapeutic oncology in the past, now with the development of “Theranostic” applications, intelligent options for targeted internal radionuclide treatments became possible in a variety of tumors and Theranostics started to give rise to a paradigm shift in oncology...